Patent row won't affect Gilead's Sovaldi launch

January 28, 2015 1:38 PM

14 0

American drug manufacturer Gilead Pharma in a formal announcement on Monday stated that it will expand the licence agreement with eight Indian firms for including its experimental medicine to treat all the six forms of Hepatitis C.

Gilead also stated that the latest decision by the patent office, which denied patent for one of its molecules, does not affect its India plans.

Read more

To category page